After the initial fracture in postmenopausal women, where do subsequent fractures occur?
- PMID: 34124629
- PMCID: PMC8176125
- DOI: 10.1016/j.eclinm.2021.100826
After the initial fracture in postmenopausal women, where do subsequent fractures occur?
Abstract
Background: The locations of subsequent fractures after initial fracture in postmenopausal women are poorly characterized.
Methods: We conducted a prospective analysis of subsequent fractures after initial fracture in Women's Health Initiative (1993-2018) participants who provided follow-up (mean 15.4 years, SD 6.2 years) data (n = 157,282 participants; baseline age 50-79; 47,458 participants with incident fracture). Cox proportional hazards models were adjusted for age, race/ethnicity, body mass index, and other covariates.
Findings: The risk of each type of subsequent fracture was increased after each type of initial fracture. Incident lower arm/wrist fracture was associated with significantly elevated risks of subsequent fractures at the upper arm/shoulder, upper leg, knee, lower leg/ankle, hip/pelvis, and spine (adjusted hazard ratios [aHRs] ranging 2·63-5·68). The risk of hip fracture was increased after initial lower arm or wrist fracture (aHR 4·80, 95% CI 4·29-5·36), initial upper arm or shoulder fracture (aHR 5·06, 95% CI 4·39-5·82), initial upper leg fracture (aHR 5·11, 95% CI 3·91-6·67), initial knee fracture (aHR 5·03, 95% CI 4·20-6·03), initial lower leg/ankle fracture (aHR 4·10, 95% CI 3·58-4·68), and initial spine fracture (aHR 6·69, 95% CI 5·95-7·53). Associations were significant in all age groups, even women aged 50-59 years. Risks of subsequent fracture were more pronounced among non-Hispanic Black, Hispanic/Latina, and Asian/Pacific Islander than among non-Hispanic White women.
Interpretation: Increased risk of subsequent fracture is observed for all fracture types across all ages. Women who experience any of these fractures should be targeted for interventions to prevent subsequent fractures.
Funding: National Institutes of Health HHSN268201600018C,HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, and HHSN268201600004C.
Keywords: Fracture; Osteoporosis.
© 2021 The Authors.
Conflict of interest statement
TG reports grants from National Heart, Lung, and Blood Institute, during the conduct of the study. RH reports grants from NHLBI, during the conduct of the study. KJ reports grants from NIH, during the conduct of the study. AL reports grants from National Institutes of Health, NHLBI, during the conduct of the study. KS reports grants from Merck & Co., outside the submitted work. JW-W reports grants from NHLBI, during the conduct of the study. MS reports grants from American Cancer Society, grants from The Centers for Disease Control and Prevention, grants from Florida Department of Health, outside the submitted work. The other authors have nothing to disclose.
Figures
References
-
- Khosla S., Cauley J.A., Compston J. Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. 2017;32(3):424–430. - PubMed
-
- Wysowski D.K., Greene P. Trends in osteoporosis treatment with oral and intravenous bisphosphonates in the United States, 2002-2012. Bone. 2013;57(2):423–428. - PubMed
-
- (NCQA) NCoQA . (NCQA) NCoQA; 2017. Osteoporosis testing and management in older women who had a fracture.https://www.ncqa.org/hedis/measures/osteoporosis-testing-and-management-... accessed 2/25/2019.
Grants and funding
LinkOut - more resources
Full Text Sources
